Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Rosenthal AK, Lawrence RA. Calcium Pyrophosphate Deposition Disease. N Engl J Med.2016;374:2575–84. This review comprehensively covers all pertinent information regarding CPPD disease, including the key risk factors and associated condition. https://doi.org/10.1056/NEJMra1511117.
2. Abhishek A. Calcium pyrophosphate deposition disease. Curr Opin Rheumatol. 2016;28:133–9. https://doi.org/10.1097/BOR.0000000000000246.
3. Rho YH, Zhu Y, Zhang Y, Reginato AM, Choi HK. Risk factors for pseudogout in the general population. Rheumatology (Oxford). 2012;51:2070–4. https://doi.org/10.1093/rheumatology/kes204.
4. Ryu K, Iriuchishima T, Oshida M, Kato Y, Saito A, Imada M, Aizawa S, Tokuhashi Y, Ryu J. The prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint. Osteoarthritis Cartilage. 2014;22(7):975–9. https://doi.org/10.1016/j.joca.2014.04.022.
5. Ramonda R, Musacchio E, Perissinotto E, Sartori L, Punzi L, Corti MC, Hirsch R, Manzato E, Zambon S, Baggio G, Crepaldi G. Prevalence of chondrocalcinosis in Italian subjects from northeastern Italy. The Pro.V.A. (PROgetto Veneto Anziani) study. Clin Exp Rheumatol. 2009;27:981–4.